Cadsys (India) (CADSYS)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹200 |
| Market Cap | ₹200.06 Cr |
| P/E Ratio | 0 |
| ROCE | -16.91% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -82.85% |
| Debt/Equity | — |
| Sales Growth | 15.05% |
| Promoter Holding | 47.78% |
| 52-Week Range | ₹35.6 — ₹200 |
| Sector | Commercial Services & Supplies |
Strengths
- Sales grew 15%, showing the business still attracts demand
- Promoter holding at 47.78% keeps management's interests partially aligned
- Quarterly revenue of ₹69 Cr indicates a meaningful operating base
- Price is above the 52-week low of ₹35.60, suggesting some market floor
Concerns
- Net loss of ₹22 Cr in the latest quarter exceeds the entire ₹47 Cr market cap
- ROCE is deeply negative at -16.91% and Piotroski F-score is only 3/9
- Profit growth down 82.85%, with zero dividend and no meaningful P/E
- Book value and debt figures are unavailable, leaving financial health opaque
AI Analysis
Friends, when I see a business like Cadsys, I am reminded of a simple rule: we first seek to avoid losses, not to make gains. This company had ₹69 Cr in quarterly sales, yet lost ₹22 Cr in that same quarter. That means the enterprise is burning cash at a pace that far exceeds its entire market capitalisation of ₹47 Cr. The ROCE is a negative 16.91%, and the Piotroski F-score is a dismal 3 out of 9. These are not numbers of a sound enterprise. Sales grew 15%, but profit growth collapsed by 82.85%. Growth without profitability is merely a faster road to ruin. I cannot calculate a P/E or book value because the data is insufficient, but I can see the promoter holding is nearly 48%, which gives some hope of skin in the game. Yet even with aligned promoters, a business that loses money on every rupee of sales and offers no dividend is a candidate for the too-hard pile. In Berkshire's early days, we avoided such situations unless there was a clear path to margin improvement. Here, I see none from these figures. The 52-week range of ₹35.60 to ₹74.40 shows volatility, but a falling knife has no handle. In Graham's language, this is not an investment; it is speculation on a turnaround. I would demand a wide margin of safety, detailed financial statements, and evidence of cost control before even thinking of buying. For now, I will simply say: in the casino of the stock market, this is not a game I would choose to play.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer